Benznidazole is a nitroimidazole antiparasitic agent indicated for the treatment of Chagas disease caused by the parasite Trypanosoma cruzi. It functions by interfering with mitochondrial respiration within… Read more
Benznidazole is a nitroimidazole antiparasitic agent indicated for the treatment of Chagas disease caused by the parasite Trypanosoma cruzi. It functions by interfering with mitochondrial respiration within the parasite, proving most effective in the early stages of infection. To support the rigorous analytical requirements of pharmaceutical development and quality control, this category includes reference standards for Benznidazole alongside key related compounds. These include pharmacopeial and non-pharmacopeial impurities, such as N-nitroso benznidazole, which must be monitored to ensure product safety and compliance. Laboratories also utilize metabolic studies and impurity profiling supported by metabolites like 2,3,4-trihydroxybenzyl alcohol. Furthermore, the inclusion of stable isotope labelled compounds like Benznidazole-D7 provides essential internal standards for accurate quantitative analysis and method validation in complex biological matrices, ensuring high precision throughout the lifecycle of drug formulation and testing.